SBIR/STTR Research Award
High-Content Analysis Tools for Developmental Toxicity Screens in Zebrafish
Award amount
$203,224Program and phase
SBIR · Phase IAward year
2009Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PHYLONIX PHARMACEUTICALS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PHS2009-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): The zebrafish has become an important new animal model for drug screening, target identification, and validation of various disease models. Although progress has been made in adapting image based high- content screening systems, there are several challenges for automation. To date, the quantitative evaluation of zebrafish assays is performed semi-manually at best, which constitutes a significant bottleneck in terms of workflow and screening cost. In Phase I research, we will specialize software algorithms that will enable automated quantitative assessment of various toxicity endpoints, thus allowing the screening of a large number of potentially toxic compounds. PUBLIC HEALTH RELEVANCE: Use of zebrafish as an alternative animal model for drug screening can greatly accelerate the drug screening process, decrease costs, and provide more accurate results than cell-based assays.
Technology keywords
Not reported